Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(13%)
Results Posted
0%(0 trials)
Terminated
1(6%)

Phase Distribution

Ph not_applicable
5
31%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

16

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)
Other(7)

Detailed Status

unknown6
Completed5
Recruiting2
Withdrawn1
Suspended1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
2
Success Rate
83.3%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

withdrawn16%
completed531%
suspended16%
recruiting213%
terminated16%
unknown638%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials

All 16 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
16